Johnson & Johnson takes over vaccine production at Baltimore plant after 15 million doses were ruined

Error ruins 15 million dosages of Johnson & Johnson's COVID-19 vaccines

Johnson & Johnson, with the aid of President Joe Biden’s administration, has been put in charge of a Baltimore vaccine production plant that ruined 15 million doses of its COVID-19 vaccine and has moved to stop British drugmaker AstraZeneca Plc from utilizing the facility to avoid any future mistakes, senior federal health officials said.

The decision was put into action by the US Department of Health and Human Services and will allow the Emergent BioSolutions plant to focus on making the single-dose Johnson & Johnson COVID-19 vaccine. Johnson & Johnson confirmed the move on Saturday, stating that it was “assuming full responsibility regarding the manufacturing of drug substance” at Emergent. The change comes after the disclosure that Emergent, which is a manufacturing partner to both AstraZeneca and Johnson & Johnson, mixed up ingredients from the two coronavirus vaccines in a case of human error, causing regulators to delay authorization of the facility’s vaccine production. The mixup ruined nearly 15 million Johnson & Johnson doses.